Literature DB >> 31043410

A FATal Combination: Fibroblast-Derived Lipids and Cancer-Derived Autotaxin Promote Pancreatic Cancer Growth.

Giulia Biffi1,2, David A Tuveson1,2.   

Abstract

In this issue of Cancer Discovery, Auciello and colleagues find that in the pancreatic cancer microenvironment activated fibroblasts secrete specific lipids that provide a source of biomass production and signaling molecules for cancer cells, fueling their proliferation and migration. Targeting of this stromal-tumor metabolic cross-talk impairs pancreatic cancer progression and represents a new potential therapeutic opportunity.See related article by Auciello et al., p. 617. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31043410     DOI: 10.1158/2159-8290.CD-19-0273

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  3 in total

Review 1.  Evolving Treatment Paradigms for Pancreatic Cancer.

Authors:  Rami Abbassi; Roland M Schmid
Journal:  Visc Med       Date:  2019-11-07

2.  Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.

Authors:  Tatiana Hurtado de Mendoza; Evangeline S Mose; Gregory P Botta; Gary B Braun; Venkata R Kotamraju; Randall P French; Kodai Suzuki; Norio Miyamura; Tambet Teesalu; Erkki Ruoslahti; Andrew M Lowy; Kazuki N Sugahara
Journal:  Nat Commun       Date:  2021-03-09       Impact factor: 14.919

Review 3.  Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.

Authors:  Chloé Laplagne; Marcin Domagala; Augustin Le Naour; Christophe Quemerais; Dimitri Hamel; Jean-Jacques Fournié; Bettina Couderc; Corinne Bousquet; Audrey Ferrand; Mary Poupot
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.